Genmab A/SGMABNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-2.65%
20245.30%
202388.65%
202275.58%
2021-65.37%
2020385.14%
201930.67%
2018-36.14%
2017384.86%
20165.22%